Latest Asx Small Caps News

Page 6 of 24
Tetragon Energy has entered its first full quarter as an ASX-listed explorer with $3.96 million in cash and an expanded plan to use seismic data to attract a farm-in partner. The company is also reassessing an onshore gas discovery that could support power generation in northern Luzon.
Victor Sage
Victor Sage
30 Oct 2026
Sunshine Metals has advanced three Queensland development threads, with Liontown’s preliminary study outlining $179.8 million in estimated net operating cashflow after capital and Mt Moss still targeting first gold in mid-2027. The gains come with a funding question, as the company held $15.2 million in cash at quarter-end and has a financing update due in November.
Maxwell Dee
Maxwell Dee
30 Oct 2026
Australian Rare Earths has produced its first Mixed Rare Earth Hydroxide at the Koppamurra pilot plant while extending an interpreted carbonatite system at Overland by roughly 5km. The operating progress comes with two important qualifiers: Koppamurra still needs further product refinement and Overland assays remain pending.
Maxwell Dee
Maxwell Dee
30 Oct 2026
Waratah Minerals has expanded its Spur Gold Project across multiple targets, led by a 46-metre intercept grading 7.27g/t gold at Consols. The company also completed the Ironclad lease acquisition and ended the quarter with A$44.46 million in cash and listed investments.
Maxwell Dee
Maxwell Dee
30 Oct 2026
Resource Minerals International has identified multiple high-grade gold-silver quartz veins and a large copper-molybdenum-bismuth soil anomaly at Wadi Salamah in Saudi Arabia. The exploration progress comes with drilling and assay results still ahead, while RMI ended the quarter with A$477,000 in cash.
Maxwell Dee
Maxwell Dee
30 Oct 2026
Blue Star Helium has recorded its first commercial helium sales from the Pinon Canyon plant in Colorado, delivering five tube trailers during the September quarter. The milestone comes with an extended offtake agreement through March 2027, but production growth still depends on permits, well development and funding.
Victor Sage
Victor Sage
30 Oct 2026
AusQuest’s Cangallo discovery in Peru continues to grow, with broad copper intersections and geophysics outlining a porphyry system at least 2.5km by 1km. The exploration momentum comes alongside a sharp cash warning, with $2.1 million on hand representing only 0.41 quarters of funding at the reported spending rate.
Maxwell Dee
Maxwell Dee
30 Oct 2026
Australian Gold and Copper has expanded the high-grade Evergreen discovery in NSW while pushing towards an initial mineral resource estimate. The exploration momentum is substantial, but the company’s reported 1.93-quarter funding runway puts future drilling and financing firmly on the agenda.
Maxwell Dee
Maxwell Dee
30 Oct 2026
Truscott Mining is preparing a 3,000 to 4,000 metre diamond drilling program at its Westminster gold project, with drilling intended to support a JORC 2012 resource estimate. The ASX-listed explorer ended September with A$626,000 in cash and reported estimated funding for 3.62 quarters, including an unused facility.
Maxwell Dee
Maxwell Dee
30 Oct 2026
Great Northern Minerals has secured permits and a drilling contractor for an approximately 2,000 metre maiden RC campaign at Iron Butte, where four undrilled chargeability anomalies sit around an existing inferred resource. Douglas Creek has also produced three or more new targets, but both projects remain at the exploration stage and will need drilling to validate the geological interpretations.
Maxwell Dee
Maxwell Dee
29 Oct 2026
Bulletin Resources has expanded gold targets at Lake Rebecca, with soil sampling and geophysics defining new anomalies ahead of possible first-pass RC drilling. The explorer ended September with $11.63 million in cash and listed investments, although its stake in troubled Matsa Resources adds a separate layer of uncertainty.
Maxwell Dee
Maxwell Dee
29 Oct 2026
Vectus Biosystems has secured FDA acceptance of a pre-IND Type B meeting for VB0004, a key regulatory step for its idiopathic pulmonary fibrosis programme. The biotech ended September with $410,000 in cash and reported estimated funding for just 1.33 quarters of operations.
Ada Torres
Ada Torres
29 Oct 2026

Browse the archive

Full archive